Academic Radiology
Volume 16, Issue 5 , Pages 546-550 , May 2009

Personal Invitations for Population-based Breast Cancer Screening

Received 31 October 2008 ,Accepted 2 February 2009.

References 

  1. Sarkeala T, Anttila A, Forsman H, et al. Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. Eur J Cancer. 2004;40:2116–2125
  2. Fracheboud J, de Koning HJ, Boer R, et al. Nationwide breast cancer screening programme in the Netherlands. Results of initial and subsequent screening 1990-1995. Int J Cancer. 1998;75:694–698
  3. Fracheboud J, de Koning HJ, Beemsterboer PMM, et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer. 1999;81:912–917
  4. Fracheboud J, de Koning HJ, Boer R, et al. Nationwide breast cancer screening programme fully implemented in the Netherlands. Breast. 2001;10:6–10
  5. European Community . European guidelines for quality assurance in mammography screening. 3rd Ed. Luxembourg: Office for Official Publications of the European Communities; 2001;
  6. Jorgensen KJ, Goetsche P. Content of invitations for publicly funded screening mammography. BMJ. 2006;332:538–541
  7. Mäkelä M, Saalasti-Koskinen U, Saarenmaa I, Autti-Rämö I. The impact of an extension of breast cancer screening. Update of Finohta' s report 16/2000. Helsinki, Finland: Finnish Office for Health Technology Assessment; 2006;
  8. In:  Perry N,  Broeders M,  de Wolf C, et al. editor. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th Ed. Luxembourg: Office for Official Publications of the European Communities; 2006;
  9. Irving L, McCaffery K, Salkeld G, Bossuyt P. Informed choice for screening: implications for evaluation. BMJ. 2006;332:1148–1150
  10. Dominighetti G, D' Avanzno B, Berrino F, Perneger T, Mosconi P, Zwahlen M. Women' s perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol. 2003;32:816–821
  11. Chamot E, Perneger TV. Misconceptions about efficacy of mammography screening: a public health dilemma. J Epidemiol Community Health. 2001;55:799–803
  12. Barratt A, Howard K, Irwig L, Salkeld G, Houssami N. Model of outcomes of screening mammography: information to support informed choices. BMJ. 2005;330:936
  13. Marshall T, Adab P. Informed consent for breast screening: what should we tell women?. J Med Screen. 2003;10:22–26
  14. Sarkeala T, Hakama M, Saarenmaa I, Hakulinen T, Forsman H, Anttila A. Episode sensitivity in association with process indicators in the Finnish breast cancer screening program. Intl J Cancer. 2006;118:174–179
  15. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:347–360
  16. Gøtzsche PC, Hartling OJ, Nielsen M, et al. Breast screening: the facts — or maybe not. BMJ. 2009;338:446–448

PII: S1076-6332(09)00081-6

doi: 10.1016/j.acra.2009.02.002

Academic Radiology
Volume 16, Issue 5 , Pages 546-550 , May 2009

Article Tools

* Image Usage & Resolution